1. Home
  2. ALM vs SYRE Comparison

ALM vs SYRE Comparison

Compare ALM & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ALM

Almonty Industries Inc.

HOLD

Current Price

$19.05

Market Cap

6.6B

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$70.54

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALM
SYRE
Founded
N/A
2013
Country
United States
United States
Employees
342
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
6.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
ALM
SYRE
Price
$19.05
$70.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
12
Target Price
$22.33
$85.08
AVG Volume (30 Days)
4.1M
809.9K
Earning Date
05-20-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$817.94
N/A
Revenue Next Year
$158.05
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.16
$13.93
52 Week High
$24.41
$78.80

Technical Indicators

Market Signals
Indicator
ALM
SYRE
Relative Strength Index (RSI) 48.63 50.41
Support Level $19.08 $65.93
Resistance Level $21.91 $76.16
Average True Range (ATR) 1.42 3.88
MACD 0.06 -0.88
Stochastic Oscillator 49.18 44.26

Price Performance

Historical Comparison
ALM
SYRE

About ALM Almonty Industries Inc.

Almonty Industries Inc is engaged in the development of the Sangdong Mine in South Korea, and the Company is currently mining, processing, and shipping tungsten concentrate from the Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal (Panasqueira Mine). Additionally, the Company is evaluating its molybdenum project with inferred mineral resources on a separate property adjacent to the tungsten orebody at the Sangdong Mine, its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora (Valtreixal Mine), and the newly-acquired Gentung Browns Lake tungsten project located in Montana, USA (Gentung-Browns Lake Project). The company has two geographical locations: the Iberian Peninsula (Spain and Portugal) and the Republic of Korea.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: